Neuropsychopharmacology
- The nosology of addiction as a medical condition: a concise history and review of contemporary perspectives2 months ago
- Striatal and hippocampal contributions to value-based learning in adolescence2 months ago
- Transdiagnostic prevention in youth mental health, Part II: interventions2 months ago
- Transcription factors Lef1 and Rest stimulate recovery from depressive states2 months ago
- Preclinical efficacy of the muscarinic agonist ML-007 in psychosis models depends on both M1 and M4 receptors2 months ago
- Early-life neural correlates of behavioral inhibition and anxiety risk2 months ago
- In Memoriam Peter Charles Whybrow, M.D., D.P.M., M.B., F.R.C.P2 months ago
Journal of Psychopharmacology
- Community-based causal evidence that high habitual caffeine consumption alters distinct polysomnography-derived sleep variables2 months ago
- The effects of lithium on cognition in humans: A systematic review2 months ago
- Effects of electroconvulsive shock on astroglial reactivity in a rat model of antipsychotic-induced neurotoxicity2 months ago
- Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs2 months ago
- A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer2 months ago
- β-blockers’ neuropsychiatric risks: Overlooked evidence?2 months ago
- Efficacy and adverse effect profile of vortioxetine in major depressive disorder: A meta-analysis2 months ago
European Neuropsychopharmacology
- Esketamine in bipolar depression: Are we overlooking critical subgroups and dosing details?2 months ago
- Reply to Jianjie Ju and Hui Chen2 months ago
- The potential of applying large-scale multi-omics data to unsupervised learning-based transdiagnostic clusters of individuals with severe mental disorders to identify pharmacodynamic targets3 months ago
- Editorial Board3 months ago
- Repurposing glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of depression: A systematic review of preclinical, observational and clinical investigations3 months ago
- Methodological gaps in treatment-resistant depression prediction3 months ago
- Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis3 months ago